• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植后不同移植物抗宿主病靶器官中的细胞因子谱。

Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation.

机构信息

Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

Cell Transplant. 2012;21(9):2033-45. doi: 10.3727/096368912X653110. Epub 2012 Jul 26.

DOI:10.3727/096368912X653110
PMID:22840591
Abstract

Previous studies using genetic-deficient murine models suggest that different T-helper subsets may contribute to different types of tissue damages in graft-versus-host disease (GvHD). However, there is limited information available on the distribution of T-helper cytokines in the various GvHD target tissues. In the current study, an acute GvHD murine model was set up to directly assess the in situ cytokine profiles in various GvHD tissue lesions; in addition, we also studied GvHD tissues from patients who had undergone bone marrow transplantation procedures. We observed that interferon-γ (IFN-γ was dominant in murine liver and gastrointestinal tissue lesions, whereas IFN-γ and interleukin 17 (IL-17) were abundant in murine skin lesions. Furthermore, in human GvHD tissues, interleukin 4 (IL-4) and IFN-γ were predominant in liver lesions and colon lesions, respectively, while no specific cytokine was prevalent in human GvHD skin lesions. In addition, a low ratio of CD4(+) T helper (Th) versus CD8(+) T cytotoxic (Tc) cells in human GvHD tissue lesions, especially in the liver, was detected, and this contrasts with the situation in murine GvHD tissues where CD4(+) Th cells were predominant. Dual staining for CD markers and cytokine expression showed that IFN-γ-secreting T cells were enriched in all murine GvHD target tissue lesions, and Tc1 and Tc2 cells were predominant in human GvHD colon and liver sections, respectively. However, IFN-γ(+) Th1, IL-17(+) Th17, IFN-γ(+) Tc1, and IL-17(+) Tc17 cells were slightly more frequent in human skin lesions compared to IL-4(+) Th2 and IL-4(+) Tc2 cells. To sum up, these results suggest that differences in cytokine imbalances may significantly contribute to tissue-specific pathogenesis in GvHD target organs, and CD8(+) Tc cells may play an important role in human GvHD induction.

摘要

先前的研究使用遗传缺陷型小鼠模型表明,不同的 T 辅助细胞亚群可能导致移植物抗宿主病(GvHD)中的不同类型组织损伤。然而,关于 T 辅助细胞因子在各种 GvHD 靶组织中的分布,信息有限。在本研究中,建立了急性 GvHD 小鼠模型,以直接评估各种 GvHD 组织损伤中的原位细胞因子谱;此外,我们还研究了接受骨髓移植手术的 GvHD 患者的组织。我们观察到,在小鼠肝和胃肠道组织损伤中,干扰素-γ(IFN-γ)占主导地位,而在皮肤损伤中 IFN-γ 和白细胞介素 17(IL-17)丰富。此外,在人类 GvHD 组织中,白细胞介素 4(IL-4)和 IFN-γ分别在肝损伤和结肠损伤中占优势,而在人类 GvHD 皮肤损伤中没有特定的细胞因子占优势。此外,在人类 GvHD 组织损伤中,特别是在肝脏中,检测到 CD4+T 辅助(Th)与 CD8+T 细胞毒性(Tc)细胞的比例较低,这与小鼠 GvHD 组织中 CD4+Th 细胞占优势的情况形成对比。CD 标志物和细胞因子表达的双重染色显示,IFN-γ 分泌 T 细胞在所有 GvHD 靶组织损伤中富集,而 Tc1 和 Tc2 细胞在人类 GvHD 结肠和肝脏切片中分别占优势。然而,与 IL-4+Th2 和 IL-4+Tc2 细胞相比,IFN-γ+Th1、IL-17+Th17、IFN-γ+Tc1 和 IL-17+Tc17 细胞在人类皮肤损伤中更为常见。总之,这些结果表明,细胞因子失衡的差异可能对 GvHD 靶器官的组织特异性发病机制有重要贡献,CD8+Tc 细胞可能在人类 GvHD 的诱导中发挥重要作用。

相似文献

1
Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation.造血干细胞移植后不同移植物抗宿主病靶器官中的细胞因子谱。
Cell Transplant. 2012;21(9):2033-45. doi: 10.3727/096368912X653110. Epub 2012 Jul 26.
2
Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.产生白细胞介素-17的辅助性T细胞作为介导异基因干细胞移植患者移植物抗宿主病的新潜在因素。
Transplantation. 2009 Dec 15;88(11):1261-72. doi: 10.1097/TP.0b013e3181bc267e.
3
The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.体外光化学疗法对慢性皮肤移植物抗宿主病细胞内细胞因子表达的影响。
J Eur Acad Dermatol Venereol. 2004 May;18(3):279-84. doi: 10.1111/j.1468-3083.2004.00814.x.
4
Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.Th2细胞和Tc2细胞在移植物抗宿主病、移植物抗白血病效应及移植物排斥反应调控中的作用:白血病和淋巴瘤异基因移植治疗的思考
Leuk Lymphoma. 2000 Jul;38(3-4):221-34. doi: 10.3109/10428190009087014.
5
Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.急性和慢性小鼠移植物抗宿主病早期过程中Th1和Th2细胞因子产生的动力学。供体CD8 + T细胞的调节作用。
J Immunol. 1995 Sep 1;155(5):2396-406.
6
Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.体外雷帕霉素可产生具有增强的体内功能和对移植后雷帕霉素治疗的不同敏感性的Th1/Tc1或Th2/Tc2效应T细胞。
Biol Blood Marrow Transplant. 2006 Sep;12(9):905-18. doi: 10.1016/j.bbmt.2006.05.014.
7
Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.急性移植物抗宿主病发展过程中产生效应性γ干扰素和白细胞介素-17的T细胞亚群的动态调节
Mol Med Rep. 2016 Feb;13(2):1395-403. doi: 10.3892/mmr.2015.4638. Epub 2015 Dec 4.
8
Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.雷帕霉素通过干扰Th1或Th1细胞毒性细胞因子的产生,抑制引发移植物抗宿主病和移植物抗白血病的T细胞的生成。
J Immunol. 1998 Jun 1;160(11):5355-65.
9
Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.移植物抗白血病效应和移植物抗宿主病中的同种特异性CD8 + Tc1和Tc2细胞群
J Immunol. 1996 Dec 1;157(11):4811-21.
10
The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.同种异体骨髓移植后急性移植物抗宿主病中 IL-22 产生 T 细胞的鉴定和特征。
Immunobiology. 2013 Dec;218(12):1505-13. doi: 10.1016/j.imbio.2013.05.005. Epub 2013 May 20.

引用本文的文献

1
Interleukin Networks in GVHD: Mechanistic Crosstalk, Therapeutic Targeting, and Emerging Paradigms.移植物抗宿主病中的白细胞介素网络:机制性相互作用、治疗靶点及新出现的模式
Int J Mol Sci. 2025 Sep 4;26(17):8620. doi: 10.3390/ijms26178620.
2
Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice.滤泡辅助性T细胞和外周辅助性T细胞样细胞在人类免疫系统小鼠中引发自身免疫性疾病。
Elife. 2025 Apr 28;13:RP99389. doi: 10.7554/eLife.99389.
3
Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice.
表达抗前列腺干细胞抗原嵌合抗原受体(CAR)和白细胞介素-15的现成不变自然杀伤T细胞可促进小鼠胰腺癌消退。
J Clin Invest. 2025 Apr 15;135(8). doi: 10.1172/JCI179014.
4
Interspecies transcriptome profiles of human T cell activation and liver inflammation in a xenogeneic graft-versus-host disease model.异种移植物抗宿主病模型中人类T细胞活化和肝脏炎症的种间转录组图谱。
Heliyon. 2024 Nov 28;10(23):e40559. doi: 10.1016/j.heliyon.2024.e40559. eCollection 2024 Dec 15.
5
Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipients.异基因造血细胞移植受者静脉补充维生素C的可行性
EJHaem. 2024 Aug 27;5(5):1043-1047. doi: 10.1002/jha2.995. eCollection 2024 Oct.
6
Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system.使用基于 Quantum pBac 的 CAR-T 工程系统制造靶向 CD20/CD19 的 iCasp9 可调节性 CAR-TSCM 细胞。
PLoS One. 2024 Aug 27;19(8):e0309245. doi: 10.1371/journal.pone.0309245. eCollection 2024.
7
OBSERVE: guidelines for the refinement of rodent cancer models.注意:啮齿类动物癌症模型改良指南。
Nat Protoc. 2024 Sep;19(9):2571-2596. doi: 10.1038/s41596-024-00998-w. Epub 2024 Jul 11.
8
Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression.嵌合抗原受体修饰的间充质基质细胞增强免疫抑制作用。
Nat Biomed Eng. 2024 Apr;8(4):443-460. doi: 10.1038/s41551-024-01195-6. Epub 2024 Apr 1.
9
Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia Effect.移植物抗宿主病的实验性减轻而不消除移植物抗白血病效应。
Cell Transplant. 2024 Jan-Dec;33:9636897241226573. doi: 10.1177/09636897241226573.
10
Animal Welfare in Radiation Research: The Importance of Animal Monitoring System.辐射研究中的动物福利:动物监测系统的重要性
Vet Sci. 2023 Nov 10;10(11):651. doi: 10.3390/vetsci10110651.